SCHEMBL4725945

SCHEMBL4725945

CN1CCN(S(=O)(=O)Cc2ccc(N)cc2)CC1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.71
LMNA P02545 1/20 0.53
USP2 O75604 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
TSHR P16473 2/20 0.47
HPGD P15428 1/20 0.47
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.44
KMT2A Q03164 2/20 0.44
MAPT P10636 1/20 0.44
ADRA2C P18825 1/20 0.44
GFER P55789 1/20 0.44
PTK2B Q14289 1/20 0.44
ESR2 Q92731 1/20 0.44
NPC1 O15118 1/20 0.44
CYP2C19 P33261 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23727751 0.84 HPGD (0.61) L3MBTL1TSHRHPGDKDM4EALDH1A1
SCHEMBL1425543 0.84 HPGD (0.66) L3MBTL1TSHRHPGDKDM4EALDH1A1
SCHEMBL2929978 0.83 L3MBTL1 (0.71) L3MBTL1USP2SMN1; SMN2TSHRHPGD
SCHEMBL10077130 0.83 L3MBTL1 (0.71) L3MBTL1TSHRHPGDKDM4EALDH1A1
SCHEMBL7401505 0.83 HPGD (0.69) L3MBTL1TSHRHPGDKDM4EALDH1A1
SCHEMBL12448379 0.81 L3MBTL1 (0.49) L3MBTL1TSHRHPGDKDM4EALDH1A1
SCHEMBL8898560 0.81 POLB (0.55) L3MBTL1TSHRHPGDALDH1A1KMT2A
SCHEMBL4188852 0.80 LMNA (0.50) L3MBTL1LMNASMN1; SMN2TSHRHPGD
SCHEMBL8220304 0.79 HPGD (0.46) L3MBTL1TSHRHPGDKDM4EALDH1A1
SCHEMBL8898022 0.78 L3MBTL1 (0.64) L3MBTL1LMNAUSP2SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008024634-A1 PYRIMDINE COMPOUNDS USEFUL AS KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-28 WO disclosed
WO-1997020822-A1 QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST NOVARTIS AG (CH) 1997-06-12 WO disclosed